Skip to main content

Table 3 Baseline characteristics of the included patients according to the GS tertiles

From: Predictive efficacy of neutrophil-to-lymphocyte ratio for long-term prognosis in new onset acute coronary syndrome: a retrospective cohort study

 

1st tertile ≤ 45 (n = 250)

2nd tertile 49–85 (n = 246)

3rd tertile ≥ 85 (n = 241)

t/Z/χ2

P

Sex (male/female)

171/79

191/55

200/41

14.814

0.001

Age (years)

55.37 ± 12.26

58.23 ± 11.84a

60.53 ± 12.34ab

11.111

 < 0.001

Hypertension

106 (42.4)

111 (45.1)

114 (47.3)

1.199

0.549

Diabetes mellitus

45 (18.0)

66 (26.8)

82 (34.0)ab

16.381

 < 0.001

Diabetes mellitus treatment

   

0.846

0.932

 Diet only

2 (4.2)

3 (6.7)

3 (4.7)

  

 Oral hypoglycemic drugs

23 (47.9)

19 (42.2)

32 (50.0)

  

 Insulin

23 (47.9)

23 (51.1)

29 (45.3)

  

Smoking

   

9.963

0.041

 Never smoker

134 (53.6)

119 (48.4)

104 (43.2)

  

 Former smoker

16 (6.4)

13 (5.3)

8 (3.3)

  

 Current smoker

100 (40.0)

114 (46.3)

129 (53.5)

  

Alcohol drinking

   

1.053

0.902

 Never drinking

147 (58.8)

153 (63.2)

146 (60.6)

  

 Former drinking

41 (16.4)

36 (14.9)

39 (16.2)

  

 Current drinking

62 (24.8)

53 (21.9)

56 (23.2)

  

Family history of CAD

95 (38.0)

100 (40.7)

102 (42.3)

0.972

0.615

SBP (mmHg)

123.72 ± 20.64

122.37 ± 18.87

121 ± 19.85

1.157

0.315

DBP (mmHg)

76.86 ± 13.88

77.45 ± 13.12

75.62 ± 13.3

1.174

0.310

Heart rate

80.42 ± 14.05

81.78 ± 14.26

83.68 ± 16.58

2.930

0.054

BMI (kg/m2)

24.78 ± 5.95

24.9 ± 5.05

25.11 ± 5.36

0.203

0.817

HDL-C (mmol/l)

0.96 ± 0.23

0.99 ± 0.26

1.01 ± 0.28

2.152

0.117

LDL-C (mmol/l)

2.88 ± 0.85

2.94 ± 0.74

3.04 ± 1

1.434

0.239

TC (mmol/l)

4.63 ± 1.23

4.57 ± 0.98

4.68 ± 1.34

0.374

0.688

TG (mmol/l)

2.14 ± 2.15

2.15 ± 2.13

1.98 ± 1.45

0.426

0.653

ApoA1 (g/L)

1.2 ± 0.26

1.23 ± 0.3

1.29 ± 0.53

2.710

0.067

ApoB (g/L)

0.9 ± 0.27

0.88 ± 0.23

0.96 ± 0.52

2.433

0.089

Lp(a) (g/L)

234.48 ± 232.84

263.47 ± 280.29

222 ± 172.39

1.505

0.223

Cr (mmol/L)

80.9 ± 35.25

80.52 ± 42.9

78.84 ± 52.29

0.150

0.860

BUN (mmol/l)

5.71 ± 2.91

5.59 ± 2.87

5.5 ± 1.95

0.394

0.674

Uric acid (μmol/L)

326.22 ± 92.64

335.89 ± 94.27

324.19 ± 92.59

1.090

0.337

WBC

10.88 ± 3.74

10.87 ± 3.71

10.64 ± 3.29

0.339

0.712

Neutrophil count

8.13 ± 3.63

8.37 ± 3.58

8.11 ± 3.15

0.419

0.658

lymphocyte count

1.95 ± 1.27

1.76 ± 0.96

1.81 ± 1.07

1.954

0.142

NLR

5.24 ± 3.90

6.41 ± 5.24

7.46 ± 5.51

12.506

 < 0.001

NLR tertiles

   

19.287

0.001

 1st tertile

104 (41.6)

77 (31.3)

64 (26.6)

  

 2nd tertile

84 (33.6)

84 (34.1)

77 (32.0)

  

 3rd tertile

62 (24.8)

85 (34.6)

100 (41.5)

  

Monocyte count

0.59 ± 0.32

0.58 ± 0.32

0.57 ± 0.31

0.258

0.773

PLR

158.09 ± 122.37

176.51 ± 159.31

166.74 ± 142.57

1.042

0.353

RBC

4.75 ± 0.70

4.74 ± 0.73

4.79 ± 0.72

0.399

0.672

HGB

145.15 ± 24.97

142.77 ± 27.85

144.62 ± 24.6

0.579

0.561

PLT

223.74 ± 69.67

242.01 ± 203.23

224.52 ± 77.66

1.508

0.222

MPV

10.20 ± 1.29

10.16 ± 1.75

10.2 ± 1.28

0.065

0.937

PDW

13.66 ± 3.35

13.44 ± 3.78

12.98 ± 3.63

2.298

0.101

PCT

0.24 ± 0.08

0.24 ± 0.11

0.24 ± 0.10

0.239

0.788

Clinical diagnosis

   

1.672

0.796

 UA

38 (15.2)

32 (13.0)

30 (12.4)

  

 NSTEMI

32 (12.8)

26 (10.6)

29 (12.0)

  

 STEMI

180 (72.0)

188 (76.4)

182 (75.5)

  

 Aspirin

18 (7.2)

23 (9.3)

33 (13.7)

5.923

0.052

 Statins

17 (6.8)

19 (7.7)

31 (12.9)ab

6.029

0.043

 β-Blockers

15 (6.0)

12 (4.9)

17 (7.1)

1.027

0.598

 ACEI/ARB

7 (2.8)

8 (3.3)

12 (5.0)

1.828

0.401

 CCB

32 (12.8)

34 (13.8)

36 (14.9)

0.470

0.790

  1. Abbreviations are as in Table 1